Melbourne-based executive, founder and advisor
Helping health innovation move from the lab and the clinic into the market
Matt began his career as a cardiac technician in the NHS and went on to lead commercial teams for global medtech companies. Today he leads business growth for health sciences and design research at Swinburne University of Technology, serves as CEO of the Australian Society for Medical Entrepreneurship & Innovation, and advises ventures through his consulting firm, Melbourne Scientific.
Commercial leadership across medtech, digital health and clinical research, built in the United Kingdom, Europe, the United States and Australia.
International representation
Matt has represented Australian health and life sciences innovation on government trade missions to Israel, Japan and the United States, and has built his career across Europe and the United Kingdom.
Speaking and representation
Matt's trade missions have been run through Austrade, Global Victoria and the City of Melbourne Lord Mayor's Mission. During his time at CROW Clinical, he was invited to join the Global Victoria delegation to Israel, where he represented Australia's medtech research capability.
He was an invited guest at the executive reception hosted by Victoria's Deputy Premier, the Hon Ben Carroll, at the Australia Pavilion at Expo 2025 Osaka, Kansai. He has also attended a reception at Government House Victoria hosted by the Governor of Victoria for the Vice Governor of Aichi Prefecture.
The Department of Foreign Affairs and Trade engaged Matt as a speaker and organiser for its Biotech Showcase event for international consuls-general. He works closely with Invest Victoria and mRNA Victoria to support life sciences investment and commercialisation in both directions.
Forums Matt has addressed
About Matt
Matt has followed health innovation along its whole path, from the clinic where he started to the devices, trials and commercial strategy that bring new products to patients.
Matt Hallam started his working life as a cardiac technician at Glenfield Hospital in the NHS. He then completed a BSc (Hons) in Biology and Environmental Science at University College Worcester and moved into the medical device industry. He provided clinical and technical support with Intermedics and Dot Medical, and was a product specialist in cardiac electrophysiology and implantable defibrillators at Medtronic. That grounding in the clinic has shaped how he approaches every commercial role since.
He went on to develop therapies across Europe for Endocardial Solutions, then moved to Australia, where he worked with St. Jude Medical and began a long career at Johnson & Johnson's Biosense Webster. There he rose from product specialist to field sales manager. He then moved to the United States to lead worldwide commercial excellence, building global launch training and competency frameworks and supporting the company's launch strategy for Japan. His work earned him the Johnson & Johnson Credo Award and Standard of Leadership Award.
Returning to Australia, Matt led sales teams across the southern region for Abbott Vascular and ran the cardiac rhythm management business for Sorin Group across Australia and New Zealand, which was recognised as the group's fastest-growing business unit worldwide. As Managing Director, Oceania for Merit Medical, he turned a distributor-led presence into a fully operational direct business. He built every function from finance and regulatory affairs to logistics and sales, and led the acquisition and integration of Intellimedical and ITL Healthcare.
From there Matt moved into the systems that bring new health products into being. He held full regional responsibility for Citeline across Australia, New Zealand and Southeast Asia, and ran national digital health and AI programs for the Digital Health CRC with partners including Stanford, UNSW, the University of Queensland, Microsoft and NSW Health. As Chief Operating Officer of CROW Clinical, he helped turn a clinical support provider into a full contract research organisation. He has since advised Evrima Technologies on partnership strategy across Australia and the United States, served as Interim CEO of OOXii Global, and led revenue at the ASX-listed TrialKey.
Today Matt brings all of this experience to researchers, clinicians and founders who want to turn a strong idea into a sustainable venture.
What drives the work
Matt helps good ideas in health reach the people who need them by connecting researchers, clinicians, industry and investors.
What Matt does now
Matt's current roles connect university research, clinical entrepreneurs and industry, so that promising health ideas find a commercial path.
Senior Manager, Business Growth Services, Innovation & Enterprise
Matt leads business growth and commercialisation for Swinburne's School of Health Sciences and School of Design and Architecture. He turns research into market propositions and builds pathways through licensing, spin-outs and industry partnerships, working with government, funding bodies and industry to align commercialisation with state and federal priorities.
Chief Executive Officer
ASME strengthens Australia's medical entrepreneurship and clinical innovation ecosystem. Matt sets its strategic direction and delivers its national programs, including AUSCEP and the CLINICIAN+ webinar series, while building relationships with government, universities and clinical networks.
Founder and CEO
Matt's consulting firm supports commercialisation and R&D in digital health, neuromodulation, oncology and medical devices. It works with startups, contract research organisations and multinationals on device trials, regulatory planning and international expansion, including in-theatre support and trial design.
How Matt helps
Matt works with people who are close to a promising health innovation but still need to find the commercial path. He has launched products in the clinic, built companies from the ground up and taken ideas through trials.
Turning a clinical insight into a product with a clear market, a credible route to revenue and a plan for the team that will deliver it, including segmentation, positioning and pricing.
Matt has designed device trials, supported procedures in theatre and helped build a contract research organisation. He helps ventures understand how trials are designed, recruited and delivered, and what sponsors and investors expect to see.
As a former TGA Responsible Person for a large portfolio of registered devices, Matt helps founders plan their evidence, regulatory pathway and reimbursement strategy together, so they are ready for market when their product is.
With experience across the United Kingdom, Europe, the United States, Oceania and Southeast Asia, Matt helps ventures decide where to launch first and how to grow across borders, and supports life sciences investment with Victorian Government bodies.
At Merit Medical, Matt negotiated and integrated the acquisitions of Intellimedical and ITL Healthcare. He helps companies assess, negotiate and absorb acquisitions while keeping the core business moving.
Matt has served as a non-executive director and reported to boards across his executive roles. He helps leadership teams prepare for boards and investors, and connects them with the government and funding bodies that shape health innovation.
Focused conversations on a specific product, pathway question or decision.
Scoped work through Melbourne Scientific, tied to a defined outcome such as a trial plan, market entry case or diligence review.
A steady external advisor through product development, fundraising or market preparation.
Keynotes, panels, board roles and mentoring for founders and clinical entrepreneurs.
Career journey
Choose a chapter to see the roles behind it.
Matt now leads business growth at Swinburne, heads ASME and advises ventures through Melbourne Scientific.
Matt moved into the data, recruitment and operations side of clinical research with Citeline, the Digital Health CRC, CROW Clinical, Evrima Technologies, OOXii Global and TrialKey.
Matt turned a distributor-led presence in Oceania into a direct business and led the acquisitions of Intellimedical and ITL Healthcare through integration.
Matt led sales at Abbott Vascular and grew Sorin Group's cardiac rhythm management business into the group's fastest-growing unit worldwide.
Matt rose from product specialist to leading worldwide commercial excellence programs in the United States, earning the Credo and Standard of Leadership awards.
Matt began as a cardiac technician in the NHS before moving into cardiac devices with Intermedics, Dot Medical, Medtronic, Endocardial Solutions and St. Jude Medical.
Education
University College Worcester, United Kingdom, where he was awarded University Sporting Colours.
Awards and recognition
Boards, mentoring and community
Alongside his executive roles, Matt has served on boards, co-founded ventures and communities, and mentored the next generation of founders.
Matt mentors founders and students on commercialisation, clinical trials, the regulatory landscape and global strategy through these programs.
Common questions
Most conversations start with a concern, a decision or an idea that needs a clear next step. That is enough to reach out.
Yes. Early-stage founders are a large part of Matt's mentoring work through AUSCEP, Melbourne Actuator, MUBES, BrainSTEM and Luminate. An outside view at that stage can help a team avoid assumptions that become costly to unwind later.
Yes. His role at Swinburne is focused on turning research into licences, spin-outs and industry partnerships, and he understands how university, government and industry priorities fit together.
Yes. Through Melbourne Scientific he has supported device trials, trial design and in-theatre work, and he has held senior roles with a contract research organisation, a trial recruitment company and a trial intelligence company.
Matt has worked across the United Kingdom, Europe, the United States and the Asia Pacific. He supports both inbound and outbound life sciences investment and commercialisation.
Use the contact form and choose speaking or board enquiry. Include the organisation, the audience or role, and any timing.
Contact
Matt is always glad to hear about new ideas in health, whether that is advisory work, speaking, a board role or mentoring.
He will be in touch soon.